US2009064238 PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

1. (WO2010123524) PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS

National Phase

Notices

Drawings

Documents

Latest bibliographic data on file with the International Bureau

Pub. No.:		WO/2010/123524		International Application No.:		PCT/US2009/064238
Publication Date:		28.10.2010		International Filing Date:		12.11.2009

IPC:

A61K 39/13 (2006.01), A61K 39/08 (2006.01), A61K 39/112 (2006.01)

Applicants:

SALUBRIOUS PHARMACEUTICALS LLC [US/US]; 123679 Calabasas Road, Suite 388 Calabasas, CA 91302 (US) (For All Designated States Except US).
NELSON, George [US/US]; (US) (For US Only)

Inventors:

NELSON, George; (US)

Agent:

DERGOSITS, Michael, E.; Dergosits & Noah LLP Three Embarcadero Center, Suite 410 San Francisco, CA 94111 (US)

Priority Data:

12/426,838

20.04.2009

Title

(EN) PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS AND NON-VIRAL BASED CANCERS
(FR) PROCÉDÉS DE TRAITEMENT D'UNE SCLÉROSE LATÉRALE AMYOTROPHIQUE, D'UNE POLYARTHRITE RHUMATOÏDE, DE LA MALADIE DES TREMBLEMENTS/DE PARKINSON, D'UNE SCLÉROSE EN PLAQUE ET DE CANCERS À BASE NON VIRALE

Abstract:

(EN)The present invention provides a composition and method for treating diseases associated with demyelination of the nerves, such as ALS, RA, Tremors/Parkinson's Disease, and MS, and for treating non-viral based cancers. By administering measured doses of an immunity-provoking agent and a bacterial antigen activator, patients suffering from ALS, RA, MS. Tremors/Parkinson's Disease, and prostrate cancer realized immediate beneficial results with no side effects.
(FR)La présente invention porte sur une composition et un procédé de traitement de maladies associées à une démyélinisation des nerfs, telles que la SLA, la polyarthrite rhumatoïde, la maladie des tremblements/de Parkinson et la sclérose en plaque et pour traiter des cancers à base non virale. Par l'administration de doses mesurées d'un agent provoquant l'immunité et d'un activateur d'antigène bactérien, des patients souffrants de SLA, de polyarthrite rhumatoïde, de sclérose en plaque, de maladie des tremblements/de Parkinson et de cancer de la prostate ont présenté des résultats bénéfiques immédiats sans effets secondaires.

Designated States:

AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Org. (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (EAPO) (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR)
African Intellectual Property Organization (OAPI) (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).

Publication Language:	English (EN)
Filing Language:	English (EN)